ILMN

132.86

1.22% -1.64

Pre-mercato: 132.98 0.12 +0.09%

Illumina Inc (ILMN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ILMN Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$134.50

Aprire:

$134.12

Volume 24 ore:

987.62K

Relative Volume:

0.51

Capitalizzazione di mercato:

$20.18B

Reddito:

$4.34B

Utile/perdita netta:

$850.00M

Rapporto P/E:

24.32

EPS:

5.4635

Flusso di cassa netto:

$921.00M

1 W Prestazione:

+4.65%

1M Prestazione:

+6.86%

6M Prestazione:

+33.53%

1 anno Prestazione:

+86.60%

Intervallo 1D:

$132.32

$134.49

Intervallo di 1 settimana:

$126.49

$135.58

Portata 52W:

$69.83

$155.53

Illumina Inc Stock (ILMN) Company Profile

Nome

Illumina Inc

Settore

Healthcare (1114)

Industria

Diagnostics & Research (51)

Telefono

(858) 202-4500

Indirizzo

5200 ILLUMINA WAY, SAN DIEGO, CA

Dipendente

8,650

Cinguettio

@illumina

Prossima data di guadagno

2026-04-30

Ultimi documenti SEC

ILMN's Discussions on Twitter

Compare ILMN vs TMO, DHR, IDXX, A, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ILMN Illumina Inc	132.86	20.18B	4.34B	850.00M	921.00M	5.4635
TMO Thermo Fisher Scientific Inc	526.02	195.48B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	195.50	138.36B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	583.06	46.31B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	120.96	34.18B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	335.61	32.95B	3.17B	642.63M	516.49M	10.77

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-12	Downgrade	Daiwa Securities	Outperform → Neutral
2025-07-11	Downgrade	Scotiabank	Sector Outperform → Sector Perform
2025-03-04	Reiterato	Citigroup	Neutral
2025-02-28	Downgrade	HSBC Securities	Buy → Hold
2025-02-10	Downgrade	Barclays	Equal Weight → Underweight
2025-02-07	Downgrade	TD Cowen	Buy → Hold
2024-12-11	Downgrade	Citigroup	Buy → Neutral
2024-11-12	Ripresa	Morgan Stanley	Equal-Weight
2024-10-17	Aggiornamento	HSBC Securities	Hold → Buy
2024-08-28	Aggiornamento	Argus	Hold → Buy
2024-08-16	Aggiornamento	Daiwa Securities	Neutral → Buy
2024-08-14	Aggiornamento	Barclays	Underweight → Equal Weight
2024-08-14	Aggiornamento	TD Cowen	Hold → Buy
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-06-03	Ripresa	Jefferies	Hold
2024-01-16	Downgrade	HSBC Securities	Buy → Hold
2024-01-04	Downgrade	TD Cowen	Outperform → Market Perform
2023-12-18	Aggiornamento	Scotiabank	Sector Perform → Sector Outperform
2023-12-15	Aggiornamento	Bernstein	Underperform → Mkt Perform
2023-12-14	Iniziato	Guggenheim	Buy
2023-12-14	Iniziato	Stephens	Overweight
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-12-12	Downgrade	BofA Securities	Neutral → Underperform
2023-12-11	Aggiornamento	Citigroup	Sell → Neutral
2023-11-10	Downgrade	Canaccord Genuity	Buy → Hold
2023-09-28	Iniziato	Bernstein	Underperform
2023-07-05	Ripresa	JP Morgan	Neutral
2023-01-25	Downgrade	Argus	Buy → Hold
2023-01-05	Iniziato	Scotiabank	Sector Perform
2022-12-12	Downgrade	Citigroup	Neutral → Sell
2022-12-07	Iniziato	RBC Capital Mkts	Outperform
2022-10-04	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2022-09-28	Aggiornamento	Evercore ISI	In-line → Outperform
2022-08-25	Iniziato	Credit Suisse	Neutral
2022-07-13	Downgrade	Barclays	Equal Weight → Underweight
2022-01-18	Aggiornamento	Stifel	Hold → Buy
2022-01-11	Aggiornamento	Barclays	Underweight → Equal Weight
2022-01-07	Aggiornamento	BofA Securities	Underperform → Neutral
2022-01-06	Ripresa	Morgan Stanley	Equal-Weight
2022-01-06	Ripresa	Piper Sandler	Overweight
2021-10-15	Ripresa	Cowen	Outperform
2021-08-19	Downgrade	SVB Leerink	Outperform → Mkt Perform
2021-06-01	Aggiornamento	Evercore ISI	Underperform → In-line
2021-03-31	Downgrade	Atlantic Equities	Overweight → Neutral
2021-03-31	Aggiornamento	Canaccord Genuity	Hold → Buy
2021-03-03	Iniziato	Barclays	Underweight
2020-12-22	Aggiornamento	Piper Sandler	Neutral → Overweight
2020-12-17	Aggiornamento	BTIG Research	Neutral → Buy
2020-10-13	Downgrade	Guggenheim	Buy → Neutral
2020-09-30	Iniziato	Atlantic Equities	Overweight
2020-09-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2020-09-22	Downgrade	Stifel	Buy → Hold
2020-09-22	Downgrade	UBS	Buy → Neutral
2020-09-21	Aggiornamento	Guggenheim	Neutral → Buy
2020-09-21	Downgrade	JP Morgan	Overweight → Neutral
2020-09-09	Iniziato	Morgan Stanley	Equal-Weight
2020-08-07	Downgrade	Evercore ISI	In-line → Underperform
2020-08-07	Downgrade	Piper Sandler	Overweight → Neutral
2020-07-07	Downgrade	Guggenheim	Buy → Neutral
2020-04-24	Downgrade	Citigroup	Buy → Neutral
2020-04-21	Downgrade	Robert W. Baird	Outperform → Neutral
2020-01-08	Iniziato	Wells Fargo	Underweight
2020-01-07	Iniziato	Citigroup	Buy
2020-01-02	Downgrade	Evercore ISI	Outperform → In-line
2019-11-15	Iniziato	Stifel	Buy
2019-10-25	Iniziato	Guggenheim	Buy

Mostra tutto

Illumina Inc Borsa (ILMN) Ultime notizie

Apr 20, 2026

Metafoodx to Showcase Award-Winning AI Kitchen Intelligence Platform at the 2026 National Restaurant Association Show - GlobeNewswire Inc.

Apr 20, 2026

Tsinghua University brings hands-on multiomics training to young scientists - Illumina

Apr 20, 2026

UPS, Netflix, BlackRock And A Health Care Stock On CNBC's 'Final Trades'BlackRock (NYSE:BLK), Illumina - Benzinga

Apr 20, 2026

Apr 19, 2026

Illumina Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Apr 17, 2026

Illumina (ILMN), Labcorp (LH) expand precision oncology NGS collaboration - MSN

Apr 17, 2026

ILMN Stock Price, Quote & Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill

Apr 17, 2026

Apr 16, 2026

DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows - PR Newswire

Apr 16, 2026

Robeco Institutional Asset Management B.V. Trims Stock Holdings in Illumina, Inc. $ILMN - MarketBeat

Apr 16, 2026

Apr 15, 2026

Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 15, 2026

Illumina, Inc. (NASDAQ:ILMN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Apr 15, 2026

Apr 14, 2026

Illumina Inc. stock (US4523271090): Why does its genomics dominance matter more now for U.S. investo - AD HOC NEWS

Apr 14, 2026

Illumina’s Pediatric Genomics Push Tests Long Term Growth Narrative - Yahoo Finance

Apr 14, 2026

How Investors Are Reacting To Illumina (ILMN) Board Turnover And Expanded Labcorp Precision Oncology Partnership - simplywall.st

Apr 14, 2026

Illumina partners with D3b on pediatric genomic data initiative - Investing.com

Apr 14, 2026

Illumina Partners with D3b to Advance Pediatric Cancer Research - Intellectia AI

Apr 14, 2026

Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease - PR Newswire

Apr 14, 2026

Third View Private Wealth LLC Buys Shares of Illumina, Inc. - National Today

Apr 14, 2026

Third View Private Wealth LLC Buys Shares of 16,207 Illumina, Inc. $ILMN - MarketBeat

Apr 14, 2026

Massachusetts Financial Services Co. MA Invests $73.53 Million in Illumina, Inc. $ILMN - MarketBeat

Apr 14, 2026

Apr 13, 2026

Hardman Johnston Trims Illumina Stake - National Today

Apr 13, 2026